The New Era of Biologics in Atopic Dermatitis: A Review
Atopic dermatitis (AD) is a prevalent inflammatory skin disorder affecting all ages and ethnic groups. The age-dependent varying appearance and extent of pruritic lesions are accompanied by distinct individual suffering, highlighting the importance of effective treatment options. Over the past year...
Saved in:
Main Authors: | Simon Schneider, Linda Li, Alexander Zink |
---|---|
Format: | article |
Language: | EN |
Published: |
Mattioli1885
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f807247e38bb471c8cfb27ac121f3b51 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atopic Dermatitis: Epidemiology and Clinical Phenotypes
by: Annunziata Raimondo, et al.
Published: (2021) -
Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study
by: Takeshi Nakahara, et al.
Published: (2021) -
Dupilumab side effect in a patient with atopic dermatitis: a case report study
by: Albader SS, et al.
Published: (2019) -
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
by: Silvia Mariel Ferrucci, et al.
Published: (2021) -
A Pilot Study: Composition and Diversity of 16S rRNA Based Skin Bacterial Microbiome in Indonesian Atopic Dermatitis Population
by: Suwarsa O, et al.
Published: (2021)